Curated News
By: NewsRamp Editorial Staff
September 10, 2026
SS Innovations' SSi Mantra Hits 14,103 Procedures, 79% Growth
TLDR
- SS Innovations SSII grew SSi Mantra procedures 79% to 14,103 and installed base 42% to 238, positioning for FDA and CE clearances.
- SSi Mantra surgical robot completed 14,103 procedures across 12 countries with 1,500 trained physicians and over 170 procedure types.
- SS Innovations expands affordable robotic surgery globally, enabling cardiac care in Colombia, Sri Lanka debut, and Philippines telesurgery for better health access.
- SSi Mantra robot performed a 13,600-mile telesurgery between Colombia and India and 258 pediatric surgeries, showcasing remote surgical innovation.
Impact - Why it Matters
This news matters because it demonstrates the accelerating global adoption of affordable robotic surgery, which could significantly expand access to minimally invasive procedures in both developed and emerging markets. The 79% growth in procedures and 42% increase in installed systems indicate strong physician and hospital acceptance, while milestones like the first robotic cardiac surgery in Colombia and the first telesurgery in the Philippines highlight the potential to bridge geographical barriers in surgical care. As SS Innovations pursues FDA clearance and CE marking, the SSi Mantra platform could soon challenge established players in the $10 billion surgical robotics market, offering a cost-effective alternative that may drive down prices and improve patient outcomes worldwide. The company's focus on telesurgery and pediatric applications further underscores its commitment to addressing unmet needs in global healthcare.
Summary
SS Innovations International (NASDAQ: SSII) has reported substantial growth in the adoption and utilization of its SSi Mantra surgical robotic system. As of September 8, 2026, the company has completed 14,103 cumulative procedures, a 79% increase from 7,885 at the end of 2025. The installed base of SSi Mantra systems has also expanded by 42%, reaching 238 units across 12 countries, up from 168 systems previously. Approximately 1,500 physicians have been trained on the platform, which has been used for more than 170 different types of surgical procedures.
Recent international milestones include the launch of robotic cardiac surgery in Colombia, the first SSi Mantra installation in Sri Lanka, and the first telesurgery within the Philippines. The company also highlighted 258 cumulative pediatric robotic surgeries and 188 robotic telesurgeries as of August 31, including a record-setting telesurgery spanning over 13,600 miles between Colombia and India. In August, five SSi Mantra systems were used to perform 50 robotic general surgery procedures in a single day in India. Looking forward, SS Innovations anticipates U.S. Food and Drug Administration review of its SSi Mantra 510(k) premarket notification to conclude by the end of the first quarter of 2027, and expects European Union CE marking certification by year-end 2026. The company provides its proprietary SSi Mantra system and SSi Mudra surgical instruments. For more details, visit the full report at https://ibn.fm/DJILj.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations' SSi Mantra Hits 14,103 Procedures, 79% Growth
